Abstract
Background Tocilizumab (TCZ) is an anti-IL-6 agent given as second-line biotherapy in the treatment of rheumatoid arthritis (RA). Guidelines for the prescription of TCZ indicate that it must be administered...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have